Pulse Biosciences to Present at Oppenheimer Healthcare Conference
Event summary
- Pulse Biosciences will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 18, 2026.
- The presentation is scheduled for 10:40 am ET and will be available as a live and recorded webcast.
- Pulse Biosciences focuses on its proprietary nPulse™ technology using Nanosecond Pulsed Field Ablation (nsPFA).
- The company targets applications in atrial fibrillation treatment and surgical soft tissue ablation.
The big picture
Pulse Biosciences' participation in the Oppenheimer conference underscores its push into high-growth areas like atrial fibrillation treatment. The event provides a platform for the company to showcase its nsPFA technology, which differentiates itself by non-thermally clearing cells while sparing adjacent tissue. This strategic focus aligns with broader industry trends toward minimally invasive and precise medical interventions.
What we're watching
- Technology Validation
- How the presentation will position nPulse™ technology in the competitive landscape of medical ablation technologies.
- Market Expansion
- Whether Pulse Biosciences can effectively communicate its strategic pivot into atrial fibrillation and other high-impact markets.
- Investor Sentiment
- The impact of the presentation on investor confidence, particularly regarding the company's ability to execute on its pipeline.
Related topics